We are live on
!
Find out more
PA
PharVision Advisers Portfolio holdings
AUM
$9.86M
1-Year Est. Return
9.93%
This Fund
S&P 500
This Quarter
Est. Return
+0.93%
1 Year Est. Return
+9.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$198M
AUM Growth
+$19.8M
(+11%)
Cap. Flow
+$23.3M
Cap. Flow
% of AUM
11.78%
Top 10 Holdings %
Top 10 Hldgs %
3.45%
Holding
1,063
New
409
Increased
141
Reduced
117
Closed
396
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Delek US
DK
|
+$871K |
| 2 |
Broadcom
AVGO
|
+$691K |
| 3 |
Agilent Technologies
A
|
+$650K |
| 4 |
Telos
TLS
|
+$640K |
| 5 |
Pagaya Technologies
PGY
|
+$627K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Array Technologies
ARRY
|
+$730K |
| 2 |
Vertiv
VRT
|
+$639K |
| 3 |
Zevra Therapeutics
ZVRA
|
+$635K |
| 4 |
BOW
Bowhead Specialty Holdings
BOW
|
+$608K |
| 5 |
Rigel Pharmaceuticals
RIGL
|
+$581K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Industrials | 15.13% |
| 3 | Financials | 12.4% |
| 4 | Consumer Discretionary | 11.79% |
| 5 | Healthcare | 11.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Liberty Latin America Class A
LILA
$1.67B
| $166K | 0.08% |
+33,035
| New | +$182K |
|
|
GIW
602
GigCapital8
GIW
$368M
| $164K | 0.08% |
+16,607
| New | +$165K |
|
|
MOMO
603
Hello Group
MOMO
$869M
| $164K | 0.08% |
25,011
-29,450
| -54% | -$203K |
|
604
Latham Group
SWIM
$673M
| $162K | 0.08% |
25,576
+14,766
| +137% | +$103K |
|
605
PennantPark Floating Rate Capital
PFLT
$705M
| $162K | 0.08% |
17,494
-8,070
| -32% | -$73.3K |
|
606
Coty
COTY
$2.45B
| $159K | 0.08% |
+51,690
| New | +$188K |
|
607
New Mountain Finance
NMFC
$668M
| $157K | 0.08% |
+17,017
| New | +$161K |
|
608
Lifecore Biomedical
LFCR
$165M
| $156K | 0.08% |
19,041
-1,469
| -7% | -$10.9K |
|
|
CEPT
609
DELISTED
Cantor Equity Partners II
CEPT
| $154K | 0.08% |
+13,666
| New | +$154K |
|
610
Brookdale Senior Living
BKD
$3.67B
| $152K | 0.08% |
+14,112
| New | +$139K |
|
611
TFS Financial
TFSL
$5.18B
| $151K | 0.08% |
+11,249
| New | +$154K |
|
612
Ooma
OOMA
$608M
| $150K | 0.08% |
12,806
-23,440
| -65% | -$267K |
|
613
Weave Communications
WEAV
$548M
| $149K | 0.08% |
+19,600
| New | +$130K |
|
614
Crescent Energy
CRGY
$3.44B
| $148K | 0.08% |
17,683
-3,883
| -18% | -$34.1K |
|
615
Camping World
CWH
$399M
| $148K | 0.07% |
+15,166
| New | +$188K |
|
616
Accel Entertainment
ACEL
$1.01B
| $146K | 0.07% |
12,817
-10,541
| -45% | -$111K |
|
|
KLC
617
KinderCare Learning Companies
KLC
$625M
| $146K | 0.07% |
33,749
+23,493
| +229% | +$118K |
|
618
Mitek Systems
MITK
$758M
| $144K | 0.07% |
+13,655
| New | +$129K |
|
|
CEPF
619
Cantor Equity Partners IV
CEPF
$596M
| $143K | 0.07% |
+13,892
| New | +$144K |
|
620
Senseonics Holdings Inc
SENS
$256M
| $142K | 0.07% |
+25,787
| New | +$179K |
|
|
AEVA
621
Aeva Technologies
AEVA
$1B
| $142K | 0.07% |
+10,662
| New | +$152K |
|
622
ProPetro Holding
PUMP
$1.31B
| $141K | 0.07% |
+14,854
| New | +$129K |
|
|
GOOD
623
Gladstone Commercial Corp
GOOD
$627M
| $140K | 0.07% |
13,157
-12,671
| -49% | -$141K |
|
624
Aurora
AUR
$12.2B
| $140K | 0.07% |
36,463
+12,927
| +55% | +$59.2K |
|
|
VLRS
625
Controladora Vuela Compania de Aviacion
VLRS
$910M
| $138K | 0.07% |
+15,586
| New | +$113K |
|
Similar funds
BS
RG
MP
CCM
DFA
CCP
FRT
VH
PharVision Advisers's Q4 2025 Portfolio in Review
As of Q4 2025, PharVision Advisers held 1,063 positions worth $198M, up 11% from $178M the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.
PharVision Advisers deployed $23.3M of net new capital in Q4 2025, opening 409 new positions and adding to 141 existing holdings. Its largest new stake was Delek US: 24,407 shares worth $724K.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Wayfair, an estimated $510K trimmed.
- PharVision Advisers's largest Q4 2025 buy was Delek US: 24,407 shares worth $724K.
- PharVision Advisers added most to NIO in Q4 2025, an estimated $557K increase.
- PharVision Advisers's biggest Q4 2025 reduction was Wayfair, cutting an estimated $510K.
- PharVision Advisers fully exited Array Technologies in Q4 2025, selling an estimated $730K.
- PharVision Advisers's ten largest holdings make up 3.5% of its $198M portfolio in Q4 2025.
- PharVision Advisers opened 409 new positions and closed 396 in Q4 2025.
- PharVision Advisers's portfolio value rose 11% quarter-over-quarter to $198M.
Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.